Scientists in Australia have published study findings that show how abnormal protein deposits in the brain which are thought to trigger Alzheimer’s disease can be detected decades before the disease actually presents itself. This could help the development of future treatments for the disease, which currently has no cure, is the main cause of dementia, and affects nearly 36 million people globally. With a rapidly aging world populace, that number of sufferers will double by 2030 and triple by 2050, says the World Health organization. According to the study, all Alzheimer’s patients have these brain deposits, known as amyloid beta. However, not everybody who has amyloid beta deposits necessarily has Alzheimer’s. However, scientists believe that it is just a matter of time before amyloid beta deposits trigger Alzheimer’s disease.
Most of the rest of the country looks good. But what happened to Idaho?
A longtime agent has ideas about how to revamp the U.S. Department of Health and Human Services.
Forty-five percent said they were willing to give up some potential gains in exchange for loss protection, the insurer found in a survey.
Sponsored by NGL
Help your clients plan for their future now so final expenses don’t overwhelm their loved ones later.
Don’t miss crucial news and insights you need to make informed investment advisory decisions. Join ThinkAdvisor.com now!
- Free unlimited access to ThinkAdvisor.com which provides advisors, like you, with comprehensive coverage of the products, services and trends necessary to guide your clients in making critical wealth, health and life decisions.
- Exclusive discounts on ALM and ThinkAdvisor events.
- Access to other award-winning ALM websites including TreasuryandRisk.com and Law.com.
Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.